Published in Semin Cell Dev Biol on March 04, 2013
Mosaic copy number variation in human neurons. Science (2013) 3.57
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell (2014) 2.14
Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep (2014) 1.59
Somatic mosaicism: implications for disease and transmission genetics. Trends Genet (2015) 1.08
Somatic mosaicism in the human genome. Genes (Basel) (2014) 0.99
Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions. PLoS Genet (2014) 0.95
Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains. Elife (2015) 0.93
Cancer karyotypes: survival of the fittest. Front Oncol (2013) 0.90
Eph-mediated tyrosine phosphorylation of citron kinase controls abscission. J Cell Biol (2016) 0.83
Neuroepigenomics: Resources, Obstacles, and Opportunities. Neuroepigenetics (2015) 0.81
In silico molecular cytogenetics: a bioinformatic approach to prioritization of candidate genes and copy number variations for basic and clinical genome research. Mol Cytogenet (2014) 0.81
The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation. Elife (2014) 0.80
S-phase duration is the main target of cell cycle regulation in neural progenitors of developing ferret neocortex. J Comp Neurol (2015) 0.79
Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network. Science (2017) 0.76
Creation of Mice Bearing a Partial Duplication of HPRT Gene Marked with a GFP Gene and Detection of Revertant Cells In Situ as GFP-Positive Somatic Cells. PLoS One (2015) 0.75
Aneuploidy in stem cells. World J Stem Cells (2016) 0.75
Inverse changes in L1 retrotransposons between blood and brain in major depressive disorder. Sci Rep (2016) 0.75
Investigating somatic aneuploidy in the brain: why we need a new model. Chromosoma (2016) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature (1953) 47.27
Large-scale copy number polymorphism in the human genome. Science (2004) 34.64
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Genetic instabilities in human cancers. Nature (1998) 22.76
Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature (2008) 20.31
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Genetic instability in colorectal cancers. Nature (1997) 12.51
G1 phase progression: cycling on cue. Cell (1994) 11.62
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet (2001) 9.08
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14
Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science (2007) 7.69
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet (2005) 7.66
Multicolor spectral karyotyping of human chromosomes. Science (1996) 7.65
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature (2008) 7.60
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 7.27
Widespread aneuploidy revealed by DNA microarray expression profiling. Nat Genet (2000) 7.26
Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry (2007) 7.00
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science (1987) 6.89
[Study of somatic chromosomes from 9 mongoloid children]. C R Hebd Seances Acad Sci (1959) 6.88
Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell (1998) 6.79
Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry (2006) 6.68
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J (1985) 6.24
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 5.92
Multiple congenital anomaly caused by an extra autosome. Lancet (1960) 5.76
Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry (2006) 5.63
Aneuploidy and cancer. Nature (2004) 5.61
High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 5.54
Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry (2005) 5.52
Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science (2008) 5.36
The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am J Hum Genet (2001) 5.23
The genetics of autism. Pediatrics (2004) 4.93
The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature (2006) 4.80
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet (2004) 4.58
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol (2007) 4.53
Epigenetic instability in ES cells and cloned mice. Science (2001) 4.08
Identification of aneuploidy-tolerating mutations. Cell (2010) 3.73
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature (2010) 3.72
The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (1987) 3.59
Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet (2004) 3.58
The prevalence of autism. JAMA (2003) 3.57
A new trisomic syndrome. Lancet (1960) 3.52
Aneuploidy: cells losing their balance. Genetics (2008) 3.48
A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A (2007) 3.47
Aneuploidy drives genomic instability in yeast. Science (2011) 3.22
Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell (2012) 3.13
DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet (2000) 2.93
Karyotype of human ES cells during extended culture. Nat Biotechnol (2004) 2.81
47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn (1997) 2.77
Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int J Mol Med (2002) 2.74
Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70
Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med (1994) 2.69
Molecular genetics of autism spectrum disorder. Mol Psychiatry (2004) 2.61
DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci (2001) 2.60
Heterogeneity of embryonic and adult stem cells. Cell Stem Cell (2008) 2.57
Oxidative damage in Alzheimer's. Nature (1996) 2.55
Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci (2008) 2.41
Generation of neuronal variability and complexity. Nature (2006) 2.39
Comparative genomic hybridization. Annu Rev Genomics Hum Genet (2005) 2.34
A genomewide screen for autism susceptibility loci. Am J Hum Genet (2001) 2.30
Constitutional aneuploidy in the normal human brain. J Neurosci (2005) 2.28
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet (2001) 2.24
Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci U S A (2001) 2.20
Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics (2003) 2.19
Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci U S A (2002) 2.17
Rapid detection of human chromosome 21 aberrations by in situ hybridization. Proc Natl Acad Sci U S A (1988) 2.15
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci (2003) 2.14
Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci (2010) 2.12
Mechanisms of programmed cell death in the developing brain. Trends Neurosci (2000) 2.05
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00
Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS One (2007) 1.98
Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet (2005) 1.89
Whole-genome multiple displacement amplification from single cells. Nat Protoc (2006) 1.88
Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice. J Neuropathol Exp Neurol (2002) 1.87
Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84
Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A (2006) 1.83
Alzheimer's disease: the two-hit hypothesis. Lancet Neurol (2004) 1.81
DNA replication stress, genome instability and aging. Nucleic Acids Res (2007) 1.80
Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat Diagn (1991) 1.77
High risk of malignancy in mosaic variegated aneuploidy syndrome. Am J Med Genet (2002) 1.72
Future medical applications of single-cell sequencing in cancer. Genome Med (2011) 1.72
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71
Transcriptional consequences of aneuploidy. Proc Natl Acad Sci U S A (2012) 1.70
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem (1998) 1.68
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med (2007) 5.06
LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol (2010) 3.91
Lysophospholipid receptors: signaling and biology. Annu Rev Biochem (2004) 3.78
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem (2004) 3.57
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature (2005) 3.35
Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature (2008) 3.14
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol (2011) 2.85
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med (2004) 2.71
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem (2006) 2.65
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation (2006) 2.58
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A (2010) 2.49
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci U S A (2003) 2.44
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36
Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat Neurosci (2003) 2.36
Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem (2003) 2.36
Constitutional aneuploidy in the normal human brain. J Neurosci (2005) 2.28
Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem (2004) 2.17
Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J (2006) 2.12
Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol (2002) 2.06
Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med (2006) 2.01
Lysophospholipid G protein-coupled receptors. J Biol Chem (2004) 1.88
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med (2009) 1.86
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat (2009) 1.81
Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler Thromb Vasc Biol (2006) 1.80
Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci Transl Med (2011) 1.76
Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol (2008) 1.70
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2007) 1.70
Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells. Nat Biotechnol (2013) 1.69
Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem (2002) 1.68
Retracted S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc Natl Acad Sci U S A (2005) 1.57
The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology (2009) 1.56
Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab (2011) 1.52
Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci (2013) 1.52
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol (2004) 1.49
A reevaluation of tetraploidy in the Alzheimer's disease brain. Neurodegener Dis (2009) 1.47
Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J Biol Chem (2003) 1.47
Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim Biophys Acta (2008) 1.43
The end of a Chilean institute. Science (2005) 1.39
The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol (2005) 1.38
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol (2004) 1.37
Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. Gastroenterology (2009) 1.33
Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol (2012) 1.31
Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta (2002) 1.30
Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell (2009) 1.29
LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. J Biol Chem (2006) 1.28
Alteration of gene expression by chromosome loss in the postnatal mouse brain. J Neurosci (2003) 1.28
Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol (2010) 1.27
The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J (2007) 1.25
S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res (2009) 1.25
The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J Exp Med (2004) 1.24
Chromosome segregation defects contribute to aneuploidy in normal neural progenitor cells. J Neurosci (2003) 1.24
Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta (2012) 1.21
Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol (2014) 1.21
Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res (2008) 1.20
Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis. FEBS Lett (2002) 1.20
Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. J Neurosci (2007) 1.19
Aneuploid mosaicism in the developing and adult cerebellar cortex. J Comp Neurol (2008) 1.19
S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses. J Biol Chem (2008) 1.18
Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J Lipid Res (2008) 1.18
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum (2011) 1.18
LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J (2013) 1.18
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol (2007) 1.17
Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem (2005) 1.17
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. Am J Respir Cell Mol Biol (2011) 1.16
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med (2013) 1.15
Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res (2005) 1.14
Absence of LPA1 signaling results in defective cortical development. Cereb Cortex (2007) 1.14
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. Neurology (2011) 1.14
Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. J Biol Chem (2005) 1.13
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain (2008) 1.13
In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim Biophys Acta (2002) 1.12
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol (2008) 1.11
Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One (2011) 1.10
Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol Cell Neurosci (2002) 1.08
S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J (2003) 1.08
Lysophospholipid activation of G protein-coupled receptors. Subcell Biochem (2008) 1.07
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med (Berl) (2009) 1.06
Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Am J Physiol Lung Cell Mol Physiol (2011) 1.05
Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus. Mol Cell Neurosci (2008) 1.05
Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir Res (2009) 1.04
LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA). J Leukoc Biol (2007) 1.02
Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes. Brain Res (2003) 1.01
Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain (2010) 1.00
Neuronal DNA content variation (DCV) with regional and individual differences in the human brain. J Comp Neurol (2010) 1.00
Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in mice. Biol Reprod (2007) 0.99
Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. J Biol Chem (2008) 0.99
Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc Natl Acad Sci U S A (2011) 0.98
Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex. J Neurosci (2004) 0.98
Lysophosphatidic acid stimulates neuronal differentiation of cortical neuroblasts through the LPA1-G(i/o) pathway. Neurochem Int (2006) 0.97
The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. Am J Physiol Gastrointest Liver Physiol (2010) 0.97
High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation (2004) 0.96
Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rho. Mol Biol Cell (2002) 0.96
Lysophosphatidic acid stimulates astrocyte proliferation through LPA1. Neurochem Int (2007) 0.95
Lysophosphatidic acid in vascular development and disease. IUBMB Life (2009) 0.95
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain (2009) 0.95
Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. Am J Respir Cell Mol Biol (2013) 0.95
Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends Endocrinol Metab (2010) 0.94
Lysophosphatidic acid in neural signaling. Neuroreport (2002) 0.94
Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. Biol Reprod (2008) 0.94